SLIT2 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), when patients were categorized by clinical stage, a clear distinction emerged between SLIT2 promoter hypermethylated and non-hypermethylated groups.